Lipid nanoparticles (LNPs) are an ideal lipid-based drug delivery (LBDD) system for nucleic acid therapeutics. Cayman supports the development of LNPs from formulation to validation. We offer an expansive collection of lipid components for LNP formulation, services for custom lipid synthesis and LNP development, as well as tools for LNP target assessment, immunogenicity, and toxicity.